Friday, November 22, 2024
type here...
- Advertisement -spot_img

TAG

Pfizer

Sports

Health stocks are tumbling after Trump’s appointment of vaccine skeptic RFK Jr.

Admin -
Vaccine stocks have tumbled since Trump appointed vaccine skeptic Robert F. Kennedy Jr. to health...
Bussiness

Pfizer raises full-year guidance by $1.5 billion amid activist investor pressure

Admin -
Pfizer (PFE) raised its full-year guidance by $1.5 billion and posted strong third quarter earnings Tuesday. The company now expects...
Bussiness

Pfizer taps Vanguard veteran for board amid fight with Starboard

Admin -
By Svea Herbst-BaylissNEW YORK (Reuters) - Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on...
Bussiness

Pfizer’s CEO gains support of ex-execs amid activist investor talks

Admin -
Former Pfizer (PFE) executives who were reportedly working with activist investor Starboard Value days ago to help turnaround the pharma giant have switched sides.Former...
Bussiness

Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies

Admin -
Vaccine makers and analysts alike are still unclear about what a new fall respiratory virus market looks like in a post-pandemic world. But low...
Sports

Activist investor Starboard has informed Pfizer it has taken a stake

Admin -
Starboard Value has taken a stake in Pfizer, people familiar with the matter said.The drug giant's stock has dropped significantly since its 2021 COVID-19...
Bussiness

Activist investor Starboard Value takes $1 billion stake in Pfizer, WSJ reports

Admin -
TechCrunchStrictlyVC comes to TechCrunch Disrupt 2024StrictlyVC is hosting its first event inside TechCrunch Disrupt 2024, and if you’re an investor keen to mingle with...
Sports

Vaxcyte’s shares jump on ‘promising’ early data on pneumococcal vaccine

Admin -
(Reuters) - Vaxcyte's shares surged more than 30% on Tuesday after the vaccine developer said its experimental pneumococcal vaccine showed promising results in an...
Bussiness

Vaxcyte’s shares jump on ‘promising’ early data on pneumococcal vaccine

Admin -
(Reuters) - Vaxcyte's shares surged more than 30% on Tuesday after the vaccine developer said its experimental pneumococcal vaccine showed promising results in an...

Latest news

- Advertisement -spot_img

© Thestarnewstoday. All rights reserved.

About Us

Popular Category

Latest News